13-97976720-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_002271.6(IPO5):c.24G>T(p.Gln8His) variant causes a missense change. The variant allele was found at a frequency of 0.00000355 in 1,406,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000032 ( 0 hom. )
Consequence
IPO5
NM_002271.6 missense
NM_002271.6 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 4.87
Genes affected
IPO5 (HGNC:6402): (importin 5) Nucleocytoplasmic transport, a signal- and energy-dependent process, takes place through nuclear pore complexes embedded in the nuclear envelope. The import of proteins containing a nuclear localization signal (NLS) requires the NLS import receptor, a heterodimer of importin alpha and beta subunits also known as karyopherins. Importin alpha binds the NLS-containing cargo in the cytoplasm and importin beta docks the complex at the cytoplasmic side of the nuclear pore complex. In the presence of nucleoside triphosphates and the small GTP binding protein Ran, the complex moves into the nuclear pore complex and the importin subunits dissociate. Importin alpha enters the nucleoplasm with its passenger protein and importin beta remains at the pore. Interactions between importin beta and the FG repeats of nucleoporins are essential in translocation through the pore complex. The protein encoded by this gene is a member of the importin beta family. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28179726).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IPO5 | NM_002271.6 | c.24G>T | p.Gln8His | missense_variant | 4/29 | ENST00000651721.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IPO5 | ENST00000651721.2 | c.24G>T | p.Gln8His | missense_variant | 4/29 | NM_002271.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000675 AC: 1AN: 148182Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
148182
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000327 AC: 6AN: 183368Hom.: 0 AF XY: 0.0000295 AC XY: 3AN XY: 101744
GnomAD3 exomes
AF:
AC:
6
AN:
183368
Hom.:
AF XY:
AC XY:
3
AN XY:
101744
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000318 AC: 4AN: 1258640Hom.: 0 Cov.: 27 AF XY: 0.00000320 AC XY: 2AN XY: 625676
GnomAD4 exome
AF:
AC:
4
AN:
1258640
Hom.:
Cov.:
27
AF XY:
AC XY:
2
AN XY:
625676
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000675 AC: 1AN: 148182Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72150
GnomAD4 genome
AF:
AC:
1
AN:
148182
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
72150
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.78G>T (p.Q26H) alteration is located in exon 4 (coding exon 2) of the IPO5 gene. This alteration results from a G to T substitution at nucleotide position 78, causing the glutamine (Q) at amino acid position 26 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;T;T;T;T;.;T;T;T;.;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
.;.;D;.;.;D;.;.;.;.;.;.;.;D;D;D;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;.;.;.;.;.;.;.;.;.;L;.;.;L;.
MutationTaster
Benign
D;D;D;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;N;D;D;D;D;D;D;D;D;D;N;.;D;N;N
REVEL
Benign
Sift
Benign
D;D;D;D;D;D;D;D;D;D;D;D;D;.;T;D;T
Sift4G
Pathogenic
D;D;T;D;D;D;D;D;D;D;D;D;T;D;T;T;T
Polyphen
1.0, 0.95
.;.;D;.;.;.;.;.;.;.;.;.;P;.;.;P;.
Vest4
0.39, 0.40, 0.42, 0.42
MutPred
0.48
.;.;.;.;.;Gain of helix (P = 0.2059);.;.;.;.;.;.;Gain of helix (P = 0.2059);.;Gain of helix (P = 0.2059);Gain of helix (P = 0.2059);.;
MVP
MPC
1.0
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at